XML 46 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Jan. 01, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of impact on results of operations of recording stock-based compensation expense
The impact on the Company's results of operations of recording stock-based compensation expense for fiscal years 2016, 2015, and 2014 was as follows (in thousands):

 
Fiscal Years
 
2016
 
2015
 
2014
Cost of revenue
$
132

 
$
109

 
$
137

Research and development
658

 
826

 
924

Selling, general and administrative
794

 
1,064

 
1,181

Restructuring costs (1)

 
29

 

Total costs and expenses
$
1,584

 
$
2,028

 
$
2,242



(1)Stock-based compensation related to restructuring plan initiated in the second quarter of fiscal year 2015.
No stock-based compensation was capitalized during any period presented above.
Schedule of weighted average assumptions included in estimated fair value calculations for stock option grants
The following weighted average assumptions are included in the estimated fair value calculations for stock option grants:
 
 
Fiscal Years
 
2016
 
2015
 
2014
Expected term (years)
7.1

 
6.3

 
6.6

Risk-free interest rate
1.40
%
 
1.75
%
 
1.98
%
Expected volatility
52
%
 
56
%
 
58
%
Expected dividend

 

 

Schedule of shares available for grant
The following table summarizes the shares available for grant under the 2009 Plan :
 
 
Shares
Available for Grant
 
(in thousands)
Balance at January 3, 2016
2,929

Authorized

Options granted
(842
)
Options forfeited or expired
1,129

RSUs granted
(1,629
)
RSUs forfeited
789

PRSUs granted
(193
)
PRSU's forfeited or expired
449

Balance at January 1, 2017
2,632

Schedule of stock options outstanding and stock option activity and related weighted average exercise price
The following table summarizes stock options outstanding and stock option activity under the 2009 Plan, and the related weighted average exercise price, for 2016, 2015 and 2014:
 
 
Number of Shares
 
Weighted Average
Exercise Price
 
Weighted Average
Remaining Term
 
Aggregate Intrinsic
Value
 
(in thousands)
 
 
 
(in years)
 
(in thousands)
Balance outstanding at December 29, 2013
7,242

 
$
2.62

 
 
 
 
Granted
428

 
3.51

 
 
 
 
Forfeited or expired
(219
)
 
3.56

 
 
 
 
Exercised
(1,769
)
 
2.57

 
 
 
 
Balance outstanding at December 28, 2014
5,682

 
2.67

 
 
 
 
Granted
225

 
1.64

 
 
 
 
Forfeited or expired
(521
)
 
2.87

 
 
 
 
Exercised
(120
)
 
0.98

 
 
 
 
Balance outstanding at January 3, 2016
5,266

 
2.64

 
 
 
 
Granted
842

 
0.86

 
 
 
 
Forfeited or expired
(1,129
)
 
2.61

 
 
 
 
Exercised

 

 
 
 
 
Balance outstanding at January 1, 2017
4,979

 
$
2.35

 
4.06
 
$
586

Exercisable at January 1, 2017
4,078

 
$
2.59

 
2.90
 
$
199

Vested and expected to vest at January 1, 2017
4,740

 
$
2.41

 
3.78
 
$
473

Schedule of significant price ranges of options outstanding, related weighted average exercise prices and contractual life information
Significant exercise price ranges of options outstanding, related weighted average exercise prices and contractual life information at the end of 2016 were as follows:
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
Options
Outstanding
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted Average
Exercise Price
 
Options Vested and
Exercisable
 
Weighted Average
Exercise Price
 
(in thousands)
 
(in years)
 
 
 
(in thousands)
 
 
$0.78 - $0.78
4

 
2.17
 
$
0.78

 
5

 
$
0.78

0.86 - 0.86
726

 
9.68
 
0.86

 

 

0.90 - 1.32
463

 
2.62
 
0.96

 
414

 
0.92

1.63 - 1.63
731

 
1.92
 
1.63

 
731

 
1.63

2.17 - 2.76
446

 
4.04
 
2.29

 
446

 
2.29

2.78 - 2.78
1,299

 
3.08
 
2.78

 
1,299

 
2.78

2.82 - 3.39
635

 
5.20
 
3.29

 
530

 
3.28

3.48 - 3.82
185

 
5.63
 
3.60

 
164

 
3.57

3.92 - 3.92
2

 
4.28
 
3.92

 
1

 
3.92

4.17 - 4.17
488

 
0.79
 
4.17

 
488

 
4.17

$0.78 - $4.17
4,979

 
4.06
 
$
2.35

 
4,078

 
$
2.59

Schedule of share-based compensation related to RSU
The stock-based compensation related to grants of vested RSUs was $953,000, $834,000, $854,000 in 2016, 2015 and 2014, respectively. In 2016, the Company cancelled PSU's issued to certain officers, which resulted in a credit of $113,000 to the stock-based compensation.

 
RSUs & PRSUs Outstanding
 
Number of Shares
 
Weighted Average
Grant Date Fair Value
 
(in thousands)
 
 
Nonvested at December 29, 2013
225

 
$
3.17

Granted
947

 
3.74

Vested
(480
)
 
3.86

Forfeited
(42
)
 

Nonvested at December 28, 2014
650

 
3.47

Granted
1,128

 
1.46

Vested
(221
)
 
1.42

Forfeited
(122
)
 

Nonvested at January 3, 2016
1,435

 
2.30

Granted
1,822

 
0.97

Vested
(649
)
 
1.07

Forfeited
(1,238
)
 

Nonvested at January 1, 2017
1,370

 
$
1.68

Schedule of weighted average assumptions
The fair value of rights issued pursuant to the Company's ESPP was estimated on the commencement date of each offering period using the following weighted average assumptions:
 
 
Fiscal Years
 
2016
 
2015
 
2014
Expected life (months)
6.1

 
6.0


6.0

Risk-free interest rate
0.97
%
 
0.21
%

0.07
%
Volatility
59.3
%
 
55
%

49
%
Dividend yield